Sanofi India Limited has announced the appointment of Deepak Arora as its new Managing Director, effective 27 October 2025, following the recommendation of the company’s Nomination and Remuneration Committee. The appointment is subject to shareholder and Central Government approval.
Arora succeeds Rachid Ayari, who served as Interim Managing Director since July 2025. Ayari stepped down from the interim role on 26 October 2025 and will continue as Whole-time Director and Chief Financial Officer of the company.
In his new role, Arora will lead Sanofi India’s strategic direction, aligning the company’s vision with global priorities. He will focus on driving innovation, operational excellence, and agility across business functions while strengthening Sanofi’s commitment to diversity, equity, and inclusion.
Welcoming Arora to the leadership team, Aditya Narayan, Chairman of the Board, Sanofi India Limited, said:
“On behalf of the Board of Directors, I am delighted to welcome Deepak Arora as the Managing Director. His extensive pharmaceutical experience across diverse geographies aligns perfectly with our endeavour to serve patients throughout India. We are confident that under his leadership, Sanofi will continue to thrive and innovate.”
With over 30 years of experience across the pharmaceutical and healthcare sectors, Arora has held senior roles in North America, Europe, the Middle East, and Africa, contributing to business growth and organizational transformation.
Arora’s appointment marks a pivotal leadership transition for Sanofi India as the company continues to strengthen its focus on patient-centric innovation and global integration.